4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-028324
Chief Financial Officer bought 1,250 shares at $18.22 ($22,775)
From the SEC's structured data for this filing
Trades in this filing
Ruffo Frank · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-05-07 | Purchase : show line 1 in the form | +1,250 | $18.22 | $22,775 | 156,865 | D |
| Open-market purchases · 1,250 sh · avg $18.22 · $22,775 | ||||||
Loading xslF345X03/doc4.xml…